Zepp Health Corp (ZEPP)
Official siteTECHNOLOGY • CONSUMER ELECTRONICS • NYSE
Market Cap: $40.77M
Last updated: Nov 17, 2026 at 11:03 AM ET
Earnings
Dividends
Dividend Metrics
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 19.2% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 50.3, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Data
Related GNG Research
No research available
Be the first to write about ZEPP
News
ZEPP Valuation
- P/B
- 0.0x
ZEPP Profitability: Margins, ROIC and FCF
Zepp Health (ZEPP) has a gross margin of 39.1%, an operating margin of -12.6% and a net margin of -15.8%. It posts -5.2% ROIC.
- Gross margin
- 39.1%
- Operating margin
- -12.6%
- Net margin
- -15.8%
- ROIC
- -5.2%
- ROE
- -21.2%
Zepp Health Competitors
The companies most similar to Zepp Health (ZEPP) include Koss, Vuzix Corp Cmn Stk and Universal Electronics.
Sector: Technology
Companies most similar to Zepp HealthZEPP Bull Case vs Bear Case
Bear case
- ZEPP has a -15.8% net profit margin.
ZEPP Dividend
- Forward yield
- 0.0%
ZEPP Earnings Date
ZEPP reports Mar 15, 2027. The date is estimated.
ZEPP Earnings Call
The latest ZEPP earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptUpdated Nov 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About ZEPP
When does ZEPP report earnings?
Zepp Health Corp (ZEPP) is expected to report earnings on Mar 15, 2027.
Does ZEPP pay dividends?
Zepp Health Corp (ZEPP) has a dividend payment track record. See the ZEPP dividend history page for its current payment status, TTM yield, and recorded payments.
What is ZEPP's market cap?
Zepp Health Corp (ZEPP) has a market capitalization of $40.77M with a current stock price of $2.78.
ZEPP pages: Overview, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.